Work Package 6

Education and Advocacy

Objectives

1. To disseminate the findings generated in VALUE-Dx by using various forms of communication and educational activities and publications at all levels of stakeholder platforms to promote their uptake and implementation in daily clinical practice and policy
2. To develop innovative, effective ways to disseminate information for creating awareness of optimal diagnosis and prognosis of CA-ARTI to prevent unnecessary prescription and use of antibiotics, to improve coverage with antibiotics, and thus limit antibiotic resistance and associated health and socioeconomic impacts
3. To develop and to tailor materials to support the adoption of CA-ARTI-Dx in European community care settings
4. To develop and implement the VALUE-Dx Course

Murat Akova

ESCMID

Suzanne Seme

Abbott

Gioia Babini

BD

PUBLICATIONS

Interview with Croatian AMR expert Arjana Tambic Andrasevic

July 31, 2024

In this insightful interview, we engage with Dr. Arjana Tambic, a leading expert in antimicrobial resistance from Zagreb, Croatia. Dr. Tambic brings extensive experience from her roles in national and international AMR surveillance and education as she shares her perspectives on the critical challenges posed by AMR, the importance of robust surveillance systems, and the essential role of rapid diagnostics in improving antibiotic prescribing practices.

PRUDENCE and ADEQUATE-paediatric studies: the final steps

April 22, 2024

VALUE-Dx’s Closing Conference

April 22, 2024

AMR expert interview with Dr. Füsun Can

April 15, 2024

Meet Dr. Füsun Can, a medical doctor and professor in Istanbul. She leads a multidisciplinary team focused on antibiotic resistance research. With expertise in virology and a commitment to collaborative efforts, Dr. Can’s work extends beyond the laboratory, aiming to address emerging infectious disease challenges across Turkey.